Targovax ASA NOK0.10
Targovax ASA NOK0.10
6,00 %
5,300 NOK
0,30
Kurs
5,300
Hög
5,300
Förändring
6,00 %
Låg
5,000
Uppdaterad
2019-08-16
Öppen
5,000
Factsheet for Targovax ASA NOK0.10
Company Profile
Description
Targovax ASA is a clinical stage company. It is focused on developing and commercializing immuno-oncology therapies to target treatment-resistant solid tumors. The firm's proprietary platforms include ONCOS and TG peptides.
Key Stats
Website: https://www.targovax.com
Headquarter country: Norway
Employees: 4
Market Cap (at close 16-08-2019): NOK 336M
Fiscal Year Ends: december
Stats

Stats 2018 2017 2016 2015 2014
Price/Earnings
Forward Price/Earnings
Price/Free Cash Flow
Return on Assets -24,90 -20,90 -22,90 -33,10 -43,30
Return on Equity -33,30 -26,90 -29,70 -41,90 -57,90
Return on Invested Capital -29,30 -23,90 -26,50 -36,20 -50,40
Dividend


Dividend/Share:
Ex. Dividend Date:0001-01-01
Trailing Dividend Yield:
Payout Ratio:0,00
Date Currency Amount
Income Statement

Revenue 2018 2017 2016 2015 2014
Total Revenue 0,03 0,04 0,04 0,07
Gross Profit -0,01
Gross Margin % -8 613,04%
Operating Expenses 2018 2017 2016 2015 2014
EBITDA -143,00 -118,00 -119,00 -98,00 -18,00
Net income -147,00 -122,00 -122,00 -101,00 -18,00
Basic Earnings Per Share -2,72 -2,51 -3,41 -2,34 -2,28
Operating Income -0,15 -0,12 -0,12 -0,10 -0,02
Operating Margin % -541 111,11% -324 124,32% -322 997,30% -24 237,45%
Cash Flow

Cash Flow 2018 2017 2016 2015 2014
Operating Cash Flow -112,00 -107,00 -110,00 -81,00 -14,00
Capital Expenditures 0,00 0,00 0,00 0,00
Free Cash Flow -112,00 -108,00 -110,00 -81,00 -14,00
Balance Sheet

Assets 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Current Assets 166,51 276,19 185,83 185,46 67,21 14,20
Long Term Assets 371,13 367,41 339,51 359,66 0,15 0,00
Total Assets 537,64 643,61 525,35 545,11 67,36 14,20
Liabilities 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Total Current Liabilities 59,38 28,29 29,19 25,42 6,69 13,92
Long Term Liabilities 94,99 96,82
Total Liabilities 124,18 122,24
Equity 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Retained Earnings -522,48 -375,47 -253,52 -131,07 -38,84 -21,20
Treasury Stock
Total Stockholder Equity 374,70 507,16 401,17 422,87 60,67 0,28
Net Tangible Assets 4,46 140,91 62,95 64,80 60,67 0,28